House Energy & Commerce Relaunches Investigation on Tainted Heparin from China
The House Energy and Commerce Committee announced that it is relaunching its investigation into tainted heparin and calling on the Food and Drug Administration to release documents related to its response to the unsolved case of toxic and sometimes lethal…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
contaminated heparin supplies that were imported from China and given to U.S. patients. In a letter sent to the FDA, Committee Chairman Upton (R), Oversight and Investigations Subcommittee Chairman Stearns (R), and Health Subcommittee Vice Chairman Burgess (R) argued that the public deserves long-overdue answers about the contamination of this blood-thinning drug in order to prevent similar dangers in the future.